Global NGS Sample Preparation Market to reach USD 4.3 billion by 2027.Global NGS Sample Preparation Market is valued approximately at USD 1.3 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 18.7% over the forecast period 2021-2027. The genetic research investigations have been revolutionized by NGS. NGS is a cutting-edge technology that can sequence the whole human genome in a single day. NGS offers a fast-sequencing speed and increased extensibility, resulting in beneficial research and development applications. The methods for sample preparation are changing as a result of advances in sequencing technology. Pre-sequencing techniques including library preparation and target enrichment produce accurate sequencing and high-quality data. Constant advancements in the field of NGS sample preparation have led to the development of standard sample preparation methods, which has aided in the expansion of NGS sample preparation market. The market growth is driven by the key factors such as rising prevalence of infectious diseases and technical advancement in NGS platforms. For instance, Global cancer burden is expected to reach 19.3 million cases and 10 million cancer deaths in 2020, according to the International Agency for Research on Cancer (IARC) Globocan 2020. Also, according to the International Agency for Research on Cancer (IARC), 1 in 5 persons will get cancer during their lifetime, with 1 in 8 men and 1 in 11 women dying from it. As the incidence of cancer rises, additional diagnostic technologies that can be utilized to make accurate and reliable diagnoses are required. For instance, in 2019, Qiagen launched NGS panels and liquid biopsy solutions with integrated bioinformatics to help accelerate cancer research. In addition, QIAGEN and Natera announced a collaboration in March 2018 to develop cell-free DNA assays for QIAGEN's GeneReader NGS System. The company also places a premium on the creation of new products and the upgrading of its present product line. However, strict regulation associated with NGS sample preparation may impede market growth over the forecast period of 2021-2027.

In the worldwide NGS sample preparation market, North America is the leading revenue-generating region. The large share of this regional market can be attributed to favorable government and private sector initiatives for the development and adoption of NGS technologies, widespread adoption of NGS diagnostics in the region, growing NGS-based research and clinical applications in the region, growing cancer research, rising awareness of NGS services, and the presence of leading NGS companies.

Major market player included in this report are:
New England Biolabs, Inc.
Becton, Dickinson and Company
Oxford Nanopore Technologies, Ltd.
F. Hoffmann-La Roche AG
Thermo Fisher Scientific Inc.
Illumina, Inc
Beckman Coulter
Oxford Gene Technology
Pacific Biosciences of California, Inc.
Swift Biosciences Inc



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Workstations
Reagents & Consumables
By Workflow:
DNA
RNA
Target Enrichment
Quality Control
By Technology:
Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-molecule Real-time (SMRT) Sequencing
Nanopore Sequencing
Other Technologies
By Application:
Disease Diagnostics
Drug Discovery
Agricultural and Animal Research
Other Applications
By End use:
Academic Institutes and Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global NGS Sample Preparation Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors